Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta2-agonists for acute bronchitis.

J Smucny1, C Flynn, L Becker

  • 1Lafayette Family Medicine Residency, 2394 Route 11, Lafayette, USA, NY 13084. smucnyj@vax.cs.hscsyr.edu

The Cochrane Database of Systematic Reviews
|May 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A fasting-mimicking diet in patients with mild-to-moderate Crohn's disease: a randomized controlled trial.

Nature medicine·2026
Same author

Maternal immune activation alters infant attentional processing in a nonhuman primate model.

Brain, behavior, & immunity - health·2025
Same author

Objective and subjective assessment of back shape and function in persons with and without low back pain.

Scientific reports·2025
Same author

Freiburg Neuropathology Case Conference : Posterior fossa tumour 15 years after microsurgical resection of a cerebellar pilocytic astrocytoma.

Clinical neuroradiology·2024
Same author

Different Glymphatic Kinetics in Spontaneous Intracranial Hypotension.

AJNR. American journal of neuroradiology·2024
Same author

Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland.

Journal of rare diseases (Berlin, Germany)·2024
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
Same journal

Non-pharmacological interventions for anxiety and depression in Parkinson's disease.

The Cochrane database of systematic reviews·2026
Same journal

Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis.

The Cochrane database of systematic reviews·2026
See all related articles

Beta2-agonists do not appear to benefit children or adults with acute cough or bronchitis. While some patients with airflow limitation may see symptom reduction, the evidence is weak and side effects like nervousness are common.

Area of Science:

  • Pulmonary Medicine
  • Clinical Pharmacology

Background:

  • Optimal treatment for acute bronchitis remains unclear.
  • Beta2-agonists are considered due to frequent airflow limitation in acute bronchitis patients.

Purpose of the Study:

  • To evaluate the efficacy of beta2-agonists in improving acute bronchitis symptoms in patients without underlying pulmonary disease.

Main Methods:

  • Systematic review of randomized controlled trials from multiple databases (Cochrane Library, MEDLINE, EMBASE).
  • Included trials involved adults and children (>2 years) with acute bronchitis or cough without other causes, randomized to beta2-agonists versus placebo or other treatments.
  • Data extraction and quality assessment were performed independently by three reviewers.

Main Results:

Related Experiment Videos

  • No significant benefits of beta2-agonists were found in children with acute cough or in adults with acute bronchitis.
  • A subgroup analysis suggested potential symptom reduction in patients with airflow limitation, particularly those with wheezing.
  • Adverse effects, including tremor and nervousness, were more frequent in patients receiving beta2-agonists.

Conclusions:

  • No evidence supports routine beta2-agonist use for children or adults with acute cough/bronchitis without airflow obstruction.
  • Potential benefits in patients with airflow limitation are not well-supported by current data and must be balanced against adverse effects.